|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Avanir Pharmaceuticals Inc., of San Diego, said information on a diagnostic scale used to identify pseudobulbar affect (PBA) in patients with multiple sclerosis was presented at the 2004 Annual Conference of the Consortium of Multiple Sclerosis Centers in Toronto. The Center for Neurologic Study Lability Scale (CNS-LS) is a validated clinical tool used to diagnose patients with PBA. The CNS-LS is being used in an ongoing Phase III trial conducted by Avanir of Neurodex to treat PBA in MS patients.
o Biomax Solutions Inc., of Falmouth, Mass., and Geospiza Inc., of Seattle, formed an alliance to integrate bioinformatics systems and sell them to researchers working ...